Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BioArctic

BioArctic?uq=BoBgMMEs
2003 FOUNDED
PUBLIC STATUS
21-30 EMPLOYEES
BIOA B STOCK SYMBOL
$8.50 SHARE PRICE (As of Wednesday Closing)
Description

Developer of treatments, biomarkers and diagnostics designed to address the causes of diseases that affect the Central Nervous System. The company's therapeutics affect the underlying disease pathology and can hopefully stop or significantly delay disease progression, enabling patients to begin treatment more quickly, resulting in a better medical outcome.

Formerly Known As
BioArctic Neuroscience
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Stock Exchange
STO
Primary Office
  • Warfvinges väg 35
  • 112 51 Stockholm
  • Sweden

+46 08-695 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BioArctic’s full profile, request a free trial.

BioArctic Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.36 - $17.72 $625M $8.49 $0.08 280K 88.1M

BioArctic Financials Summary

In Thousands,
USD
TTM
30-Sep-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 873,761 156,077
Revenue 29,319 16,463 12,325 4,927
EBITDA 8,945 2,605 8,833 723
Net Income 6,838 1,773 6,720 440
Total Assets 116,047 139,310 77,736 15,585
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BioArctic Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore BioArctic‘s full profile, request access.

Request full access to PitchBook

BioArctic Executive Team (7)

Name Title Board
Seat
Contact
Info
Gunilla Osswald Ph.D Chief Executive Officer
Jan Mattsson Chief Financial Officer & Vice President, Finance
Christer Möller Ph.D Chief Scientific Officer & Vice President of Pre-Clinical Development
Pär Gellerfors Ph.D Co-Founder, Board Member & Senior Vice President Business Strategy
Lars Lannfelt Ph.D Co-Founder & Board Member

1 Former Executive

You’re viewing 5 of 7 executives. Get the full list »

BioArctic Board Members (6)

Name Representing Role Since Contact
Info
Eugen Steiner Ph.D Self Board Member 000 0000
Hans Ekelund Self Board Member 000 0000
Ivar Verner Self Board Member and Deputy Chairman 000 0000
Lars Lannfelt Ph.D BioArctic Co-Founder & Board Member 000 0000
Wenche Rolfsen Ph.D Self Chairman 000 0000

1 Former Board Member

You’re viewing 5 of 6 board members. Get the full list »